A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 23, 2023

Primary Completion Date

May 22, 2024

Study Completion Date

May 22, 2024

Conditions
Multiple Myeloma
Interventions
DRUG

Modakafusp Alfa

Modakafusp alfa intravenous infusion

DRUG

Daratumumab

Daratumumab SC injection

Trial Locations (27)

2139

Concord Repatriation General Hospital, Concord

3004

The Alfred Hospital, Melbourne

11706

New York Cancer and Blood Specialists, Bay Shore

11794

Stony Brook University Hospital, Stony Brook

13273

Institut Paoli-Calmettes, Marseille

37007

Fundacion Instituto de Estudios Ciencias de la Salud de Castilla y Leon-Investigacion Biomedica de Salamanca (IBSAL), Salamanca

45267

University of Cincinnati - Vontz Center for Molecular Studies, Cincinnati

46060

Fort Wayne Medical Oncology and Hematology, Inc, Fort Wayne

58128

Chonnam National University Hwasun Hospital, Hwasun

59037

CHRU Lille, Lille

63130

Washington University School of Medicine, St Louis

66211

HCA Midwest Health (Midwest Ventures Group HCA MidAmerica Division), Overland Park

68198

University of Nebraska Medical Center, Omaha

70112

Tulane University Health Sciences Center, New Orleans

77598

Cedars-Sinai Medical Center, Los Angeles

78041

Tranquil Clinical Research, Webster

85234

Banner MD Anderson Cancer Center, Gilbert

300020

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin

310003

Zhejiang University School of Medicine - The First Affiliated Hospital (Zhejiang Provincial First Hospital), Hangzhou

430022

Wuhan Union Hospital, Wuhan

510060

Sun Yat-Sen University Cancer Center, Guangzhou

02111

Floating Hospital for Children at Tufts Medical Center, Boston

07932

Summit Medical Group PA, Florham Park

J1H 5N4

Centre Hospitalier Universitaire De Sherbrooke (CHUS) - Centre de Recherche Clinique Etienne-Le Bel (CRCELB) Hopital Fleurimont, Sherbrooke

06351

Samsung Medical Center, Seoul

06591

The Catholic University of Korea, Seoul St. Marys Hospital, Seoul

08035

Hospital Universitario Vall d'Hebron, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY